Terms: = Leukemia AND IL21R, Q9HBE5, 50615, ENSG00000103522 AND Treatment
5 results:
1. IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway.
Wu K; Zhao H; Xiu Y; Li Z; Zhao J; Xie S; Zeng H; Zhang H; Yu L; Xu B
Int Immunopharmacol; 2019 Apr; 69():136-142. PubMed ID: 30708194
[TBL] [Abstract] [Full Text] [Related]
2. Mixed-species RNAseq analysis of human lymphoma cells adhering to mouse stromal cells identifies a core gene set that is also differentially expressed in the lymph node microenvironment of mantle cell lymphoma and chronic lymphocytic leukemia patients.
Arvidsson G; Henriksson J; Sander B; Wright AP
Haematologica; 2018 Apr; 103(4):666-678. PubMed ID: 29449436
[TBL] [Abstract] [Full Text] [Related]
3. CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway.
Browning RL; Mo X; Muthusamy N; Byrd JC
Oncotarget; 2015 Jun; 6(18):15931-9. PubMed ID: 26158860
[TBL] [Abstract] [Full Text] [Related]
4. The role of IL-21 in hematological malignancies.
Ma J; Ma D; Ji C
Cytokine; 2011 Nov; 56(2):133-9. PubMed ID: 21824785
[TBL] [Abstract] [Full Text] [Related]
5. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
Ueda M; Imada K; Imura A; Koga H; Hishizawa M; Uchiyama T
Br J Haematol; 2005 Jan; 128(2):169-76. PubMed ID: 15638850
[TBL] [Abstract] [Full Text] [Related]
